Status:

COMPLETED

Bicarbonate and Lipocalin in Systemic Inflammatory Response Syndrome (SIRS) Study

Lead Sponsor:

Austin Health

Conditions:

Systemic Inflammatory Response Syndrome

Oliguria

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

The investigators will determine the feasibility, safety and efficacy of intravenous sodium bicarbonate in reducing progression to overt acute renal failure in patients with the systemic inflammatory ...

Detailed Description

The investigators hypothesise: 1. In patients with SIRS and oliguria the early administration of sodium bicarbonate or sodium chloride (control) triggered by an abnormally high NGAL level is feasible...

Eligibility Criteria

Inclusion

  • Consent obtained
  • Diagnosis of SIRS. Requires any TWO of:
  • temperature \> 38°C or \< 36°C OR heart rate \> 90 beats/min OR respiratory rate \> 20 breaths/min. PaCO2 \< 32 mm Hg OR alteration of white blood cell count \> 12,000 cells/mm3, \< 4,000 cells/mm3, or the presence of \> 10% immature neutrophils
  • elevated lipocalin level
  • Arterial line already in place
  • Central venous catheter already in place
  • Age ≥ 18 years
  • Within 24 hours of admission to the ICU

Exclusion

  • Unlikely to remain in ICU for \>72 hours
  • Moribund patient
  • Pre-existing CKD, transplant or ESRD
  • Receiving (or about to receive) continuous renal replacement therapy for acute renal failure at time of enrolment
  • Diagnosis of acute GN, AIN, vasculitis or post-renal aetiology
  • Known/suspected study allergy to sodium bicarbonate
  • Enrolling physician concern about patient enrolment

Key Trial Info

Start Date :

February 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2012

Estimated Enrollment :

70 Patients enrolled

Trial Details

Trial ID

NCT00706771

Start Date

February 1 2010

End Date

September 1 2012

Last Update

June 30 2014

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Austin Hospital

Heidelberg, Melbourne, Victoria, Australia, 3084

2

Royal Melbourne Hospital

Melbourne, Victoria, Australia, 3154